Abstract

Cirrhotic patients show a reduced synthesis of both pro- and anti-coagulant factors. Recent reports indicate that they are characterized by a higher risk of thrombotic rather than hemorrhagic complications, but the mechanisms conferring this risk are not fully elucidated. Oxidative-mediated fibrinogen modifications may explain, at least in part, a prothrombotic profile. The aim of the present pilot study was to investigate the alterations in fibrinogen structure and function in patients with cirrhosis of various severity and to correlate these findings with the mechanisms of thrombus formation. We assessed in plasma specific oxidative stress markers and measured oxidative modifications, functional and structural parameters in purified fibrinogen fractions obtained from cirrhotic patients and control subjects. We enrolled 15 cirrhotic patients (5 patients belonging to each of the three Child–Turcotte–Pugh classes) and 20 age- and sex-matched healthy controls. Plasma redox status, fibrinogen oxidative modifications, thrombin-catalyzed fibrin polymerization and fibrin resistance to plasmin-induced lysis were significantly altered in cirrhotic patients and were associated to disease severity. Importantly, clot structure obtained by stimulated emission depletion (STED) super-resolution microscopy indicated modifications in fiber diameter and in clot porosity in cirrhotic patients. Fibrin fiber diameter significantly decreased in cirrhotic patients when compared to controls, and this difference became more marked with disease progression. In parallel, fibrin pore size progressively decreased along with disease severity. In cirrhotic patients, fibrinogen clot analysis and oxidative-dependent changes reveal novel structural and functional fibrinogen modifications which may favor thrombotic complications in cirrhosis.

Highlights

  • Cirrhosis is associated with complex changes in the hemostatic system

  • We investigated the possible relationship between fibrinogen structure and function in patients with cirrhosis of various severity, to elucidate the mechanisms of thrombus formation and provide additional mechanistic information on the pro-thrombotic features of this condition

  • In the present pilot study, stimulated emission depletion (STED) super-resolution microscopy revealed the presence of marked alteration in clot porosity and fibrin fiber diameter in fibrinogen fractions purified from cirrhotic patients compared to fibrin from controls

Read more

Summary

Introduction

Since the liver synthesizes the majority of coagulation factors, for a long time cirrhosis-associated coagulopathy has been considered a major contributor to bleeding complications [1]. Antioxidants 2020, 9, 737 patients the decreased levels of coagulation factors are associated with a simultaneous decrease in the levels of anticoagulant molecules. This “rebalanced hemostasis” is unstable and explains the occurrence of both bleeding and thrombotic complications [2,3]. Abnormalities in coagulation factors, slowing of portal blood flow, and endothelial injury may all contribute to thrombosis development. Several elements, including bacterial translocation, stage of disease, and severity of portal hypertension, may contribute to the development of endothelial dysfunction [8]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call